[Federal Register Volume 78, Number 75 (Thursday, April 18, 2013)]
[Notices]
[Page 23220]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-09163]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-91-2012]


Foreign-Trade Zone 22--Chicago, Illinois, Authorization of 
Production Activity, Abbott Laboratories, Inc., AbbVie, Inc. 
(Pharmaceutical Production), North Chicago, Illinois, Area

    On December 14, 2012, Abbott Laboratories, Inc., and AbbVie, Inc., 
submitted a notification for expanded production authority within 
Subzones 22F and 22S, respectively, at sites located in the North 
Chicago and Lake County, Illinois, area.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (77 FR 75610, 12-21-2012). The FTZ 
Board has determined that no further review of the activity is 
warranted at this time. The production activity described in the 
notification is authorized, subject to the FTZ Act and the Board's 
regulations, including Section 400.14.

    Dated: April 12, 2013.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2013-09163 Filed 4-17-13; 8:45 am]
BILLING CODE P